By
Jeff Dale2023-07-05T17:53:00
A California-based manufacturer of smart windows avoided civil penalties after self-reporting apparent disclosure violations to the Securities and Exchange Commission (SEC).
View failed to disclose $28 million in projected warranty-related liabilities to address defects in its products, the SEC said in a press release Monday. The agency declined to fine the company because of the latter’s prompt remediation and cooperation.
View’s former Chief Financial Officer Vidul Prakash, however, faces SEC charges for his alleged failure to ensure disclosure of the warranty-related liabilities. The agency’s complaint against Prakash, filed in U.S. District Court for the Northern District of California, seeks permanent injunctions, civil penalties, and an officer-and-director bar.
2023-08-16T19:14:00Z By Kyle Brasseur
Diversified holding company Ault Alliance agreed to pay $700,000 as part of a settlement with the Securities and Exchange Commission addressing allegations of misleading disclosures and reporting violations.
2023-06-21T14:06:00Z By Kyle Brasseur
Tool manufacturer Stanley Black & Decker avoided a civil penalty in settling with the Securities and Exchange Commission regarding alleged violations of executive perk disclosure rules.
2023-06-06T15:56:00Z By Kyle Brasseur
Electronic payments software company Cantaloupe agreed to pay a $1.5 million penalty to settle allegations of accounting fraud levied by the Securities and Exchange Commission arising from improper revenue recognition practices.
2025-11-05T18:35:00Z By Oscar Gonzalez
Approximately $9 billion of potential shadow-banking flows tied to Iranian networks in 2024, according to a new analysis from FinCEN. The report highlights how illicit funds are making their way through financial institutions as they meet the requirements of the Bank Secrecy Act (BSA).
2025-10-31T18:52:00Z By Oscar Gonzalez
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
2025-10-30T19:59:00Z By Oscar Gonzalez
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
Site powered by Webvision Cloud